Primary tumor location as a prognostic factor in metastatic colorectal cancer von Loupakis, Fotios, Yang, Dongyun, Yau, Linda, Feng, Shibao, Cremolini, Chiara, Zhang, Wu, Maus, Martin K H, Antoniotti, Carlotta, Langer, Christiane, Scherer, Stefan J, Müller, Thomas, Hurwitz, Herbert I, Saltz, Leonard, Falcone, Alfredo, Lenz, Heinz-Josef

Volltext

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer von Parikh, Aparna R, Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P, Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef

Volltext

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatment von SMITH, Kimberly Y, PATEL, Parul, WANNAMAKER, Paul, SHAEFER, Mark S, FINE, Derek, BELLOS, Nicholaos, SLOAN, Louis, LACKEY, Philip, KUMAR, Princy N, SUTHERLAND-PHILLIPS, Denise H, VAVRO, Cindy, LINDA YAU

Volltext

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomi... von Eron, Joseph, Yeni, Patrick, Gathe, Joseph, Estrada, Vicente, DeJesus, Edwin, Staszewski, Schlomo, Lackey, Philip, Katlama, Christine, Young, Benjamin, Yau, Linda, Sutherland-Phillips, Denise, Wannamaker, Paul, Vavro, Cindy, Patel, Lisa, Yeo, Jane, Shaefer, Mark

Volltext

Inference for the Complier-Average Causal Effect From Longitudinal Data Subject to Noncompliance and Missing Data, With Application to a Job Training Assessment for the Unemployed von Yau, Linda H Y, Little, Roderick J

Volltext

Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein Occlusion von Thach, Allen B., MD, Yau, Linda, PhD, Hoang, Carol, PharmD, Tuomi, Lisa, PharmD

Volltext

Statistical Techniques for Analyzing Data From Prevention Trials: Treatment of No-Shows Using Rubin's Causal Model von Little, Roderick J, Yau, Linda H. Y

Volltext

Monthly Versus As-Needed Ranibizumab Injections in Patients with Retinal Vein Occlusion von Campochiaro, Peter A., MD, Wykoff, Charles C., MD, PhD, Singer, Michael, MD, Johnson, Robert, MD, Marcus, Dennis, MD, Yau, Linda, PhD, Sternberg, Gary, MD, MBA

Volltext

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia von Salama, Carlos, Han, Jian, Yau, Linda, Reiss, William G, Kramer, Benjamin, Neidhart, Jeffrey D, Criner, Gerard J, Kaplan-Lewis, Emma, Baden, Rachel, Pandit, Lavannya, Cameron, Miriam L, Garcia-Diaz, Julia, Chávez, Victoria, Mekebeb-Reuter, Martha, Lima de Menezes, Ferdinando, Shah, Reena, González-Lara, Maria F, Assman, Beverly, Freedman, Jamie, Mohan, Shalini V

Volltext

Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials von Thach, Allen B, Yau, Linda, Hoang, Carol, Tuomi, Lisa

Volltext

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Long-term Follow-up in the HORIZON Trial von HEIER, Jeffrey S, CAMPOCHIARO, Peter A, YAU, Linda, ZHENGRONG LI, SAROJ, Namrata, RUBIO, Roman G, LAI, Phillip

Volltext

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions von Heier, Jeffrey S., MD, Campochiaro, Peter A., MD, Yau, Linda, PhD, Li, Zhengrong, PhD, Saroj, Namrata, OD, Rubio, Roman G., MD, Lai, Phillip, MD

Volltext

Modulation of K65R Selection by Zidovudine Inclusion: Analysis of HIV Resistance Selection in Subjects with Virologic Failure Receiving Once-Daily Abacavir/Lamivudine/Zidovudine an... von ROSS, Lisa, ELION, Richard, BELINDA HA, LANIER, Randall, DEJESUS, Edwin, COHEN, Calvin, REDFIELD, Robert R, GATHE, Joseph C, HSU, Ricky K, LINDA YAU, PAULSEN, D

Volltext

Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product von Vanderlaan, Martin, Maniatis, Aristides, Olney, Robert, Rahmaoui, Abdelkader, Yau, Linda, Quarmby, Valerie, Azzolino, Craig, Woods, Cynthia, Moawad, Dalia

Volltext

Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study von Campochiaro, Peter A, Wykoff, Charles C, Singer, Michael, Johnson, Robert, Marcus, Dennis, Yau, Linda, Sternberg, Gary

Volltext

Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema von Morse, Lawrence, Yau, Linda, Tuomi, Lisa

Volltext

Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bacteremia: Comparison of Clinical Features and Outcomes von Lucas, Gregory M., Lechtzin, Noah, Puryear, D. Wonder, Yau, Linda L., Flexner, Charles W., Moore, Richard D.

Volltext

Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial von Ison, Michael G., de Cassia Castro, Rita, Hurt, Aeron C., Ko, Jinnie, Yau, Linda, Kuhlbusch, Klaus, Portsmouth, Simon, Hayden, Frederick G.

Volltext

Efficacy outcomes with bevacizumab added to chemotherapy (bev+CT) compared with chemotherapy alone (CT) in left- and right-sided tumors in metastatic colorectal cancer (mCRC) von Loupakis, Fotios, Hurwitz, Herbert I., Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Yau, Linda, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef

Volltext

Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population von Rawlings, M Keith, Klein, Jennifer, Klingler, Edna P Toubes, Queen, Ejeanée, Rogers, Lauren, Yau, Linda H, Pappa, Keith A, Pakes, Gary E

Volltext